T cell subsets;Subpopulacje limfocytów T

Onkologia Polska

Volumn 8, Issue 1, 2005, Pages 17-20

  Kopeć Szlezak, Joanna ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

NKT cells; Regulatory T cells; T lymphocyte homeostatis

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR; CYTOKINE; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL LINEAGE; CELL SELECTION; CELLULAR IMMUNITY; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; INFECTION; INTESTINE CELL; LIVER CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NATURAL KILLER CELL; PROTEIN FUNCTION; T LYMPHOCYTE SUBPOPULATION;

EID: 20344393358     PISSN: 15056732     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kopeć-Szlezak J.: Grasica jako mikrośrodowisko dojrzewania limfocytów T. Onkol. Pol. 2003, 6, 167-171.
2. Abo T.: Extrathymic pathways of T-cell differentiation and immunomodulation. Int. Immunopharmacol. 2001, 1, 261-273.
3. Holm T.L., Nielsen J., Claesson M.H.: CD4+CD25+ regulatory T cells: I. Phenotype and physiology. APMIS 2004, 112, 629-641.
4. Baecher-Allan C., Viglietta V., Hafler D.A.: Human CD4+CD25+ regulatory T cells. Semin. Immunol. 2004, 16, 89-98.
5. Kronenberg M.: Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 2005, 150-160.
6. Antony P.A., Restifo N.P.: CD4+CD25+ T regulatory cells, immunotherapy of cancer and interieukine 2. J. Immunother. 2005, 28, 120-128.
7. Guiducci C., Valzasina B., Dislich H., Colombo M.P.: CD40/CD40L interaction regulates CD4+CD25+ homeostasis through dendritic cell-produced IL-12. Eur. J. Immunol. 2005, 35, 557-567.
8. Bopp, T., Palmetshofer A., Serfling E. i wsp.: NFATc2 and NFATc3 transcription factors play a crucial role in supression of CD4+ lymphocytes by CD4+CD25+ regulatory cells. J. Exp. Med. 2005, 201, 181-187.
9. Gondek D.C., Lu L.F., Quezada S.A. i wsp.: Contact mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforine independent mechanism. J. Immunol. 2005, 174, 1783-1786.
10. Cozzo C., Larkin J., Caton A.J.: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J. Immunol. 2003, 171, 5678-5682.
11. Hoffmann P., Ermann J., Edinger M. i wsp.: Donor-type CD4+CD25+ regulatory T cells supress lethal acute graft versus host disease after allogeneic bone marrow transplantation. J. Exp. Med. 2002, 196, 389-399.
12. Sanchez-Ramon S., Navarro A.J., Aristimuno C., Rodriguez-Mahou M.: Pregnancy induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity. Immunol. Lett. 2005, 96, 195-201.
13. Sanchez J., Casano J., Alvarez M.A. i wsp.: Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Hematol. 2004, 126, 697-703.
14. Stenstrom M., Skold M., Ericsson A. i wsp.: Surface receptors identify mouse NK1.1.+T cell subset distinguished by function and T cell receptor type. Eur. J. Immunol. 2004, 34, 56-65.
15. Dao T., Guo D., Ploss A. i wsp.: Development of CD1d-restricted NKT cells in the mouse thymus. Eur. J. Immunol. 2004, 34, 3542-3552.
16. Amprey J.L., Im S., Turco S.J. i wsp.: A subset of liver NKT cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 2004, 200, 895-904.
17. Kaneda H., Takeda K., Ota T. i wsp.: ICOS costimulates invariant NKT cell activation. Biochem. Biophys. Res. Commun. 2005, 327, 201-207.
18. Emoto M., Kaufmann S.H.E.: Liver NKT cells: an account and heterogeneity. Trends Immunol. 2003, 42, 364-369.
19. Sondel P.M., Buhtoraiev I.N., DeSantes K.: Pleasant memories: remembering immune protecion while forgetting about graft-versus-host disease. J. Clin. Invest. 2003, 112, 25-27.
20. Pearl J.P., Parris J., Hale D.A. i wsp.: Immunocompetent T cells with a memory phenotype are the dominant cell type following antibody-mediated depletion. Am. J. Transplant. 2005, 5, 465-474.
21. Casorati G., Locatelli F., Pagani S. i wsp.: Dallabona Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukaemia. Exp. Hematol. 2005, 33, 212-218.
22. Vanden Eijnden S., Goriely S., De Wit D. i wsp.: IL-23 up-regulates IL-10 and induce II-17 synthesis by activated naive T cells in human. Eur. J. Immunol. 2005, 35, 469-475.
23. Lugering A., Kucharzik T., Soler D. i wsp.: Lymphoid precursor s in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence CCR6. J. Immunol. 2003, 171, 2208-2215.
24. Shimizu Y., Minemura M., Murata H. i wsp.: Preferential accumulation of CD103+ T cells in human liver. J. Hepatol. 2003, 39, 918-924.
25. Fry T.J., Mackall C.L.: Interleukin-7: from bench to clinic. Blood 2002, 99, 3892-3902.
26. Workmann C.J., Vignali D.A.: Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J. Immunol. 2005, 174, 688-695.
27. Alpgodon O., Muriglau S.J., Eng J.M., Willis L.G.: IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 2003, 112, 1095-1107.
28. Peggs K.S., Mackinnon S.: Immune reconstitution following haematopoietic stem cell transplantation. Br. J. Haematol. 2004, 124, 407-420.